Table 2.
Treatment Regimen | No. of Patients | % of Patients |
|||
---|---|---|---|---|---|
CR | nPR | PR | NR | ||
Fludarabine-based | 113 | 30 | 27 | 27 | 13 |
FC/FM | 137 | 34 | 27 | 23 | 11 |
FCR | 345 | 70 | 10 | 14 | 3 |
Overall | 595 | 54 | 17 | 18 | 7 |
Abbreviations: CR, complete remission; nPR, nodular partial remission; PR, partial remission; NR, no response; FC, fludarabine with cyclophosphamide; FM, fludarabine with mitoxantrone; FCR, fludarabine, cyclophosphamide, and rituximab.